{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:06:57Z","timestamp":1791875217885,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371812"],"award-info":[{"award-number":["81371812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560325"],"award-info":[{"award-number":["81560325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fund for Innovative Talent of Science and Technology in University of Henan Province, China","award":["17HASTIT049"],"award-info":[{"award-number":["17HASTIT049"]}]},{"name":"Medical Leadership Foundation of Health and Family Planning Commission of Yunnan Province, China","award":["L-201613"],"award-info":[{"award-number":["L-201613"]}]},{"name":"Science and Technology Innovation Team of Sexually Transmitted Diseases of Kunming Medical University, China","award":["CXTD201609"],"award-info":[{"award-number":["CXTD201609"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12865-019-0311-2","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T04:17:03Z","timestamp":1566965823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The predictive role of CD4+ cell count and CD4\/CD8 ratio in immune reconstitution outcome among HIV\/AIDS patients receiving antiretroviral therapy: an eight-year observation in China"],"prefix":"10.1186","volume":"20","author":[{"given":"Chong-Xi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-4388","authenticated-orcid":false,"given":"Yi-Qun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"311_CR1","unstructured":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The lancet HIV 2017."},{"issue":"2","key":"311_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00002030-199902040-00008","volume":"13","author":"NG Pakker","year":"1999","unstructured":"Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS. 1999;13(2):203\u201312.","journal-title":"AIDS"},{"issue":"5322","key":"311_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1126\/science.277.5322.112","volume":"277","author":"B Autran","year":"1997","unstructured":"Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112\u20136. \n                    https:\/\/doi.org\/10.1126\/science.277.5322.112\n                    \n                  .","journal-title":"Science"},{"issue":"4 Suppl 3","key":"311_CR4","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19672","volume":"17","author":"J Saison","year":"2014","unstructured":"Saison J, Ferry T, Demaret J, Maucort-Boulch D, Venet F, Perpoint T, Ader F, Icard V, Chidiac C, Monneret G. Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia. J Int AIDS Soc. 2014;17(4 Suppl 3):19672.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"311_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/QAD.0000000000000130","volume":"28","author":"J Frater","year":"2014","unstructured":"Frater J, Ewings F, Hurst J, Brown H, Robinson N, Fidler S, Babiker A, Weber J, Porter K, Phillips RE. HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression. AIDS. 2014;28(5):699\u2013708. \n                    https:\/\/doi.org\/10.1097\/QAD.0000000000000130\n                    \n                  .","journal-title":"AIDS"},{"issue":"22","key":"311_CR6","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.4103\/0366-6999.193460","volume":"129","author":"FP Guo","year":"2016","unstructured":"Guo FP, Li YJ, Qiu ZF, Lv W, Han Y, Xie J, Li YL, Song XJ, Du SS, Mehraj V, et al. Baseline naive CD4+ T-cell level predicting immune reconstitution in treated HIV-infected late presenters. Chin Med J. 2016;129(22):2683\u201390. \n                    https:\/\/doi.org\/10.4103\/0366-6999.193460\n                    \n                  .","journal-title":"Chin Med J"},{"issue":"6","key":"311_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/COH.0b013e32833ed774","volume":"5","author":"I Sereti","year":"2010","unstructured":"Sereti I, Rodger AJ, French MA. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS. 2010;5(6):504\u201310. \n                    https:\/\/doi.org\/10.1097\/COH.0b013e32833ed774\n                    \n                  .","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"311_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/COH.0b013e328361faf4","volume":"8","author":"M Perreau","year":"2013","unstructured":"Perreau M, Levy Y, Pantaleo G. Immune response to HIV. Curr Opin HIV AIDS. 2013;8(4):333\u201340. \n                    https:\/\/doi.org\/10.1097\/COH.0b013e328361faf4\n                    \n                  .","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"311_CR9","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"C Mussini","year":"2015","unstructured":"Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, et al. CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. The lancet HIV. 2015;2(3):e98\u2013106. \n                    https:\/\/doi.org\/10.1016\/S2352-3018(15)00006-5\n                    \n                  .","journal-title":"The lancet HIV"},{"issue":"1","key":"311_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","volume":"66","author":"S Serrano-Villar","year":"2013","unstructured":"Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M, Madrid N, Dronda F, Zamora J, Munoz-Fernandez MA, et al. The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. The Journal of infection. 2013;66(1):57\u201366. \n                    https:\/\/doi.org\/10.1016\/j.jinf.2012.09.013\n                    \n                  .","journal-title":"The Journal of infection"},{"issue":"6","key":"311_CR11","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2352-3018(17)30043-7","volume":"4","author":"EC Caniglia","year":"2017","unstructured":"Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, et al. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The lancet HIV. 2017;4(6):e251\u20139. \n                    https:\/\/doi.org\/10.1016\/S2352-3018(17)30043-7\n                    \n                  .","journal-title":"The lancet HIV"},{"issue":"3","key":"311_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1086\/510746","volume":"44","author":"RD Moore","year":"2007","unstructured":"Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(3):441\u20136. \n                    https:\/\/doi.org\/10.1086\/510746\n                    \n                  .","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"311_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128393","volume":"10","author":"W Teshome","year":"2015","unstructured":"Teshome W, Asefa A. Correction: predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control study. PLoS One. 2015;10(5):e0128393. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0128393\n                    \n                  .","journal-title":"PLoS One"},{"issue":"4","key":"311_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/QAD.0b013e32833556f3","volume":"24","author":"A Guihot","year":"2010","unstructured":"Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, et al. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy. AIDS. 2010;24(4):614\u20137. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e32833556f3\n                    \n                  .","journal-title":"AIDS"},{"issue":"11","key":"311_CR15","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1172\/JCI120245","volume":"128","author":"SA Younes","year":"2018","unstructured":"Younes SA, Talla A, Pereira Ribeiro S, Saidakova EV, Korolevskaya LB, Shmagel KV, Shive CL, Freeman ML, Panigrahi S, Zweig S, et al. Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction. J Clin Invest. 2018;128(11):5083\u201394. \n                    https:\/\/doi.org\/10.1172\/JCI120245\n                    \n                  .","journal-title":"J Clin Invest"},{"key":"311_CR16","doi-asserted-by":"publisher","unstructured":"Korencak M, Byrne M, Richter E, Schultz BT, Juszczak P, Ake JA, Ganesan A, Okulicz JF, Robb ML, de Los Reyes B, et al. Effect of HIV infection and antiretroviral therapy on immune cellular functions. JCI insight. 2019;4(12). \n                    https:\/\/doi.org\/10.1172\/jci.insight.126675\n                    \n                  .","DOI":"10.1172\/jci.insight.126675"},{"issue":"1","key":"311_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/jac\/dkw369","volume":"72","author":"F Raffi","year":"2017","unstructured":"Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, et al. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course. J Antimicrob Chemother. 2017;72(1):240\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"311_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fimmu.2016.00579","volume":"7","author":"X Lu","year":"2016","unstructured":"Lu X, Su B, Xia H, Zhang X, Liu Z, Ji Y, Yang Z, Dai L, Mayr LM, Moog C, et al. Low double-negative CD3+CD4-CD8- T cells are associated with incomplete restoration of CD4+ T cells and higher immune activation in HIV-1 immunological non-responders. Front Immunol. 2016;7:579. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00579\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"12","key":"311_CR19","doi-asserted-by":"publisher","first-page":"e83514","DOI":"10.1371\/journal.pone.0083514","volume":"8","author":"NT Funderburg","year":"2013","unstructured":"Funderburg NT, Andrade A, Chan ES, Rosenkranz SL, Lu D, Clagett B, Pilch-Cooper HA, Rodriguez B, Feinberg J, Daar E, et al. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naive patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS One. 2013;8(12):e83514. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0083514\n                    \n                  .","journal-title":"PLoS One"},{"key":"311_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1471-2334-10-318","volume":"10","author":"FN Engsig","year":"2010","unstructured":"Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Roge B, Jensen J, Nielsen LN, Obel N. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis. 2010;10:318.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-019-0311-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:08:06Z","timestamp":1598483286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-019-0311-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1186\/s12865-019-0311-2","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the First Affiliated Hospital of Kunming Medical University, and written informed consents were obtained from all study participants. All experiments were performed in accordance with the approved guidelines and regulations according to the principles expressed in the Declaration of Helsinki, and the experimental protocols were approved by the institutional review boards of Kunming Medical University and Henan University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}